
The 36-month CORE-VNS study findings showed sustained seizure reduction, improved quality of life, and reduced seizure-related hospitalizations among people with drug-resistant epilepsy receiving vagus nerve stimulation therapy.
Here is new evidence that the incidence of SUDEP is higher than expected in boys, people with psychiatric comorbidities, and other groups. Details here.



